All lobbying firms
B HALL STRATEGIES, LLC
Registrant on federal lobbying filings · filed 2025 to 2026
$2,900,000
Income reported
19
Clients represented
110
Filings counted
0
Former members lobbying
Clients
19
- TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. $250,000
- TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA $250,000
- TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS $150,000
- TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. $150,000
- TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC. $150,000
- TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. $150,000
- TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC. $150,000
- TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS $150,000
- TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. $150,000
- TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC. $150,000
- TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC $150,000
- TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION $150,000
- TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. $150,000
- TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA $150,000
- TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY $150,000
- TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. $150,000
- TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC $150,000
- TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS $150,000
- TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE $0
Lobbyists named
1
- JAMES BRYANT HALL II
Reported by year
2 years
- 2026 $1,160,000
- 2025 $1,740,000
Issues lobbied
5
Agencies and chambers lobbied
2
- SENATE
- HOUSE OF REPRESENTATIVES
Recent filings
110 total
Q2
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA
Q2
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS
Q2
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC
Q2
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.
Q2
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY
Q2
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.
Q2
TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA
Q2
TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.
Q2
TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION
Q2
TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC
Q2
TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC.
Q2
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.
Q2
TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS
Q2
TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.
Q2
TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.
Q2
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.
Q2
TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.
Q2
TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS
Q2
TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE
RR
TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE